Inventor · disambiguated record
Margaret Thy Luu Nguyen
Also filed as: NGUYEN MARGARET T L · NGUYEN MARGARET THY LUU
15 granted patents·5 pending applications·119 citations·filing 2013–2023
92Inventor score
Files withCYTOMX THERAPEUTICS INC20
Top patents by PatentIndex Score
20 records- 0197US10138272B2Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Nov 27, 2018·31 cites·43 claims
- 0297US9562073B2Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2015·Granted Feb 7, 2017·32 cites·51 claims
- 0395US11028126B2Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Granted Jun 8, 2021·8 cites·54 claims
- 0495US10669339B2Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Granted Jun 2, 2020·10 cites·44 claims
- 0595US9487590B2Activatable antibodies that bind interleukin-6 receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2013·Granted Nov 8, 2016·15 cites·35 claims
- 0694US10336824B2Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Jul 2, 2019·16 cites·48 claims
- 0791US11046759B2Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Jun 29, 2021·4 cites·58 claims
- 0886US12459999B2Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·8 claims
- 0984US10611845B2Activatable antibodies that bind interleukin-6 receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2016·Granted Apr 7, 2020·2 cites·35 claims
- 1083US2024150402A1Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1182US11174316B2Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·1 cites·19 claims
- 1281US2024150478A1Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1381US2024084022A1Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1479US11548943B2Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·0 cites·9 claims
- 1579US11472875B1Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2021·Granted Oct 18, 2022·0 cites·11 claims
- 1678US11548944B2Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·0 cites·10 claims
- 1776US11884746B2Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2021·Granted Jan 30, 2024·0 cites·6 claims
- 1873US11814410B2Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2018·Granted Nov 14, 2023·0 cites·28 claims
- 1964US2020339694A1Activatable antibodies that bind interleukin-6 receptor and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2061US2015087810A1Matrix Metalloproteinase Substrates And Other Cleavable Moieties And Methods Of Use ThereofCYTOMX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Margaret Thy Luu Nguyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →